Effect of carbohydrate refeeding on free fatty acids after a fast in obese diabetic and obese non-diabetic females. 1989

D S Gray, and M Takahashi, and J S Fisler, and J LoPresti, and J T Nicoloff, and G A Bray
Department of Medicine, University of Southern California, Los Angeles.

The metabolic effects of refeeding with oral or intravenous carbohydrate were studied in obese women after ten or 14 days of fasting. Seven patients were refed with protein-free fruit juice for a total of 250 g of carbohydrate (1,000 kcal) over ten hours. The juice was sipped continuously throughout this time, causing a drop in free fatty acids (FFA) from 1.07 +/- 0.08 to 0.61 +/- 0.05 mmol/L (P less than .01) over the first four hours. Over the next four hours, despite continuous ingestion of the carbohydrate and elevated plasma glucose (132 +/- 9 mg/dL) and insulin (2.81 +/- 0.86 ng/mL) (1 ng/mL = 25 microU/mL), FFA rose to 0.99 mmol/L (P less than .01). Similar results were obtained in five patients refed with similar amounts of oral glucose and four patients who received an equivalent amount of glucose intravenously (IV). Refeeding with carbohydrate of obese diabetic and non-diabetic women after a two-week fast caused an abrupt decrease in FFA that was followed after four hours by an increase in FFA and glycerol, despite continued ingestion of carbohydrate glucose and insulin.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004040 Dietary Carbohydrates Carbohydrates present in food comprising digestible sugars and starches and indigestible cellulose and other dietary fibers. The former are the major source of energy. The sugars are in beet and cane sugar, fruits, honey, sweet corn, corn syrup, milk and milk products, etc.; the starches are in cereal grains, legumes (FABACEAE), tubers, etc. (From Claudio & Lagua, Nutrition and Diet Therapy Dictionary, 3d ed, p32, p277) Carbohydrates, Dietary,Carbohydrate, Dietary,Dietary Carbohydrate
D005215 Fasting Abstaining from FOOD. Hunger Strike,Hunger Strikes,Strike, Hunger,Strikes, Hunger
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005260 Female Females

Related Publications

D S Gray, and M Takahashi, and J S Fisler, and J LoPresti, and J T Nicoloff, and G A Bray
May 1962, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
D S Gray, and M Takahashi, and J S Fisler, and J LoPresti, and J T Nicoloff, and G A Bray
January 1970, Acta paediatrica Academiae Scientiarum Hungaricae,
D S Gray, and M Takahashi, and J S Fisler, and J LoPresti, and J T Nicoloff, and G A Bray
March 1989, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
D S Gray, and M Takahashi, and J S Fisler, and J LoPresti, and J T Nicoloff, and G A Bray
January 1973, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
D S Gray, and M Takahashi, and J S Fisler, and J LoPresti, and J T Nicoloff, and G A Bray
April 1974, Diabetologia,
D S Gray, and M Takahashi, and J S Fisler, and J LoPresti, and J T Nicoloff, and G A Bray
December 2004, Prostaglandins, leukotrienes, and essential fatty acids,
D S Gray, and M Takahashi, and J S Fisler, and J LoPresti, and J T Nicoloff, and G A Bray
February 1969, Comptes rendus hebdomadaires des seances de l'Academie des sciences. Serie D: Sciences naturelles,
D S Gray, and M Takahashi, and J S Fisler, and J LoPresti, and J T Nicoloff, and G A Bray
May 1975, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
D S Gray, and M Takahashi, and J S Fisler, and J LoPresti, and J T Nicoloff, and G A Bray
September 1967, Acta medica Scandinavica,
D S Gray, and M Takahashi, and J S Fisler, and J LoPresti, and J T Nicoloff, and G A Bray
October 1973, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
Copied contents to your clipboard!